Loci Orthopaedics is a concurrent spin-out from the University of Galway (Ireland), University College Cork (Ireland) and KU Leuven (Belgium). The company develops orthopaedic technologies to meet major unmet clinical needs with a primary focus on the orthopaedics extremities market, such as the thumb joint. The company focuses on evidence-based design to ensure that its technologies are physiologically optimal to restore natural movement for superior clinical outcomes.
Ryme Medical is a medtech company based in California developing a catheter-based therapy that seeks to reduce symptoms and improve long-term outcomes in patients with Chronic Obstructive Pulmonary Disease (COPD), a debilitating condition in which chronic inflammation of the lung airways leads to difficulty breathing. Ryme Medical is addressing the critical and unmet need of COPD which affect over 320 million people globally and ranks as the third-leading cause of death worldwide.
ShiraTronics is a medical device company located in Minneapolis. They are developing a migraine-specific device which is placed beneath the skin and is designed to provide continuous stimulation to targeted nerves associated with migraine, potentially relieving, interrupting and preventing chronic migraine symptoms.
Perfuze is based in Galway, Ireland. It develops innovative catheter technology to treat acute ischemic stroke, providing superior clinical outcomes in shorter procedural times. Perfuze has developed super-bore diameter aspiration technology that has the capability to navigate the complex neurovascular anatomy. Perfuze’ pipeline of products are designed to facilitate fast, complete clot removal during acute ischemic stroke.
Atlantic Therapeutics is a spin-out from BMR (Galway). It developed a non-invasive neuromuscular electrical stimulation device to treat various forms of incontinence (stress-urinary, faecal, and mixed-urinary). Caldera Medical acquired the company’s assets in September 2023.
Apica Cardiovascular was a developer of a platform access and closure device for the delivery of therapeutic medical devices through the apex of the heart. Apica was acquired by Thoratec in July 2014.
PQ Bypass is a medical device company working to transform the treatment of long-segment femoropopliteal disease with minimally-invasive endovascular solutions. The company was sold to Endologix in April 2021.
Veryan developed innovative stent solutions to treat peripheral vascular disease. Veryan’s BioMimics 3D Vascular Stent System has a unique 3D helical geometry to improve treatment outcomes in peripheral vascular disease. The Product is FDA approved and marketed in the US.The company was acquired by Otsuka Medical in December 2018.
Novate developed a novel inferior vena cava filter that converts from a filter to a stent, providing protection to patients at risk of pulmonary embolism.The company was sold to BTG in September 2018.
